Another study by Li Ming et al. indicated that Aspirin irreversibly inhibited enzymatic activity of COX-2, a downstream oncogenic gene regulated by NF-κB, and blocked PGE2 production in esophageal cancer cells [57]. The gene discussed is NFKB1; the disease is esophageal cancer.